Table 4.
Correlates of CNS-LS score and IEED diagnosis.
| Variable | CNS-LS score (B [SE], P value)
|
IEED diagnosis (Odds ratio [95% CI], P value)
|
||
|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |
| Age | −.05 [.03], .07 | −.04 [.03], .15 | 1.0 [1.0–1.1], .33 | – |
| Sex | 2.41 [.77], .002a | 1.61 [.78], .04 | 1.1 [0.1–10.2], .92 | – |
| Education | −.05 [.10], .60 | – | 1.0 [0.8–1.3], .41 | – |
| Disease duration | .06 [.06], .34 | – | 1.1 [1.0–1.2], .26 | – |
| MMSE score | .03 [.12], .83 | – | 0.8 [0.7–1.0], .04 | 0.9 [0.7–1.1], .29 |
| Levodopa dosage | <.01 [<.01], .62 | – | 1.0 [1.0–1.0], .20 | – |
| Dopamine agonist use | −.24 [.64], .71 | – | 1.2 [0.3–5.6], .82 | – |
| Antidepressant use | .91 [.71], .20 | – | 1.7 [0.3–9.3], .56 | – |
| UPDRS motor subscore | <.01 [.03], .88 | – | 1.1 [1.0–1.1], .03 | 1.1 [1.0–1.1], .15 |
| Hoehn & Yahr stage | .03 [.47], .94 | – | 2.2 [0.7–6.4], .16 | – |
| GDS-15 score | .32 [.08], <.001a | .27 [.08], .001a | 1.1 [1.0–1.3], .16 | – |
a
Significant after correction for multiple comparisons.